Skip to main content
. 2023 Oct 24;2023(10):CD014722. doi: 10.1002/14651858.CD014722.pub2

Li 2020b.

Methods No information on baseline data for depressive symptoms
Study design: cluster‐RCT
Country: Vietnam
Participants Family members of people who use drugs
Inclusion criteria: 
a. be at least 18 years of age
b. be a family member of the PWUD participant in the study
c. know the PWUD participant’s drug‐using status
d. live with the PWUD in the selected study commune
Exclusion criteria:
not specified
Stated purpose: to assess the intervention effect by comparing family members’ mental health and family functioning between the intervention condition and the control condition
Interventions Intervention:
name and description
The intervention was delivered in two consecutive steps. The first step was to provide intervention group CHW with training in basic behavioural change theories and skills to communicate with PWUD and their family members effectively. The second step was to have the trained CHW deliver group intervention sessions to family members of PWUD in the communes. Each session was about 1 h in length and was held in a private room in the local commune health centre. The contents of the family member’s group sessions focused on developing a healthy family routine, coping with caregiver burden, shifting perspectives to manage negative emotions, forming coalitions amongst family members, and facilitating a positive behavioural change of PWUD. The group sessions also served to address societal stigma facing family members of PWUD and develop social support links for the families to integrate into their community.
Control:
control condition (not specified)
Outcomes Participants'outcomes of interest for this review

  1. Mental health symptoms/depression – Zung Self‐Rating Depression Scale ‐ short version (SDS)


Economic outcomes
Nil
Time points: baseline, post‐intervention (12‐month follow‐up)
Notes Source of funding: National Institute on Drug Abuse of the National Institutes of Health under award number [R01DA033609] and National Institute of Mental Health of the National Institutes of Health under award number [P30MH058107].
Prospective trial registration number: not specified